Home/Protocols/Pigmentation & Melasma/DPG.cr
Pigmentation & Melasmaprodermic DPG.cr

Depigmentation for Melasma & PIH

Depigmentation
SKU DEP · 100gm · Treatment Cream
648
MRP 1,295
~10 sessions per jar · 65/session
50% Professional Margin
Per-Session Economics
What do you charge per session?3,500
1,00010,000
Your cost per session65
Your profit per session3,435
~10Sessions/jar
35,000Revenue/jar
34,350Profit/jar

Prodermic DPG.cr is a 6-agent arbutin-based depigmentation cream — a budget-friendly alternative to MLX.cr.The AKN-6D Complex combines Arbutin for competitive tyrosinase inhibition, Kojic Acid for copper chelation at the tyrosinase active site, and Niacinamide for melanosome transfer disruption. D-Panthenol and Aloe provide soothing support.Value depigmentation at ₹1,295 for price-sensitive clinics.

Indications
Depigmentation
Depigmentation
Budget Depigment
Budget Depigment
General Brightening
General Brightening
Active Agents
Arbutin
Niacinamide
Kojic Acid
D-Panthenol
Aloe Vera
Wheat Germ Oil
Volume
100gm
Sessions/Jar
~10
Peel Depth
Superficial
Fitzpatrick
Professional use
Category
Cream
Shelf Life
24 months
Dispatch
Same Day
Min Order
1 unit
Same-Day Dispatch
Zero Minimum
GMP Certified
Prodermic Certified
Prodermic® Certified Seller
Only purchase Prodermic® products from certified partners and authorized distributors to ensure genuine formulations.
Complete Protocol Stack
Recommended clinical workflow for prodermic DPG.cr
01
prodermic PREP.01
Pre-Protocol
₹348
02
prodermic DPG.cr
Depigmentation
₹648
03
prodermic NEUT.01
Neutralizer
₹448
04
prodermic REST.01
Recovery Balm
₹1,500
Total Stack2,944
Order Complete Stack
Formulation Technology

Arbutin-Kojic Depigmentation™

AKN-6DComplex

AKN-6D Complex — arbutin-kojic-niacinamide 6-agent depigmentation cream.

Application Protocol

Recommended sequence for prodermic DPG.cr. Frequency: As prescribed.

Step 01
Apply as directed by physician
Mechanism of Action
Arbutin
Competitive tyrosinase inhibition for pigment suppression.
Kojic Acid
Copper chelation at tyrosinase active site.
Niacinamide
Melanosome transfer disruption reducing pigment delivery.
Arbutin
Lead Active
Multi-agent
Total Concentration
N/A (topical)
Peel Depth
None
Aggression
Ideal Patient Profile

Price-sensitive patients needing depigmentation maintenance. Lower-cost alternative to MLX.cr.

Clinical Note

If desired results are not achieved, it does not indicate the peel is ineffective—it may simply mean that the skin has a higher tolerance to the current formulation. In such cases, consider transitioning to a stronger peel, applying multiple coats, or increasing the application time in subsequent sessions.